Garry V. Krepart

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.

K. Swenerton, J Jeffrey, Gavin Stuart et al. · Journal of Clinical Oncology · 1992 · 214 citations

The Benefits of Comprehensive Surgical Staging in the Management of Early-Stage Epithelial Ovarian Carcinoma

Tien Le, Allyson J. Adolph, Garry V. Krepart et al. · Gynecologic Oncology · 2002 · 139 citations

Gynecologic Surgery, Surgical Oncology, Gynecological Surgery +10

Does Debulking Surgery Improve Survival in Biologically Aggressive Ovarian Carcinoma?

Tung B. K. Le, Garry V. Krepart, Robert Lotocki et al. · Gynecologic Oncology · 1997 · 111 citations

Surgical Oncology, Gynecological Surgery, Medicine +8

Papillary Serous Adenocarcinoma of the Endometrium

J.F. Jeffrey, Garry V. Krepart, Robert Lotocki · Obstetrics and Gynecology · 1986 · 97 citations

Papillary Serous Adenocarcinoma, Surgical Oncology, Tumoral Pathology +10

The treatment for dysgerminoma of the ovary

Garry V. Krepart, Julian P. Smith, Felix N. Rutledge et al. · Cancer · 1978 · 96 citations

Surgical Oncology, Anderson Hospital, Cancer Management +19